Title : Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.

Pub. Date : 2012

PMID : 22942727






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein-1 (MCP-1) expression. Dipyridamole C-C motif chemokine ligand 2 Homo sapiens
2 Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein-1 (MCP-1) expression. Dipyridamole C-C motif chemokine ligand 2 Homo sapiens